| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/06/1997 | EP0787013A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 08/06/1997 | EP0787003A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
| 08/06/1997 | EP0786999A1 Combination method for acne treatment |
| 08/06/1997 | EP0786995A1 Use of receptor potentiators |
| 08/06/1997 | EP0786994A2 Use of chloride channel blockers for reducing intraocular pressure |
| 08/06/1997 | EP0786988A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs |
| 08/06/1997 | EP0593774B1 Food composition which inhibits formation of intestinal putrefaction product |
| 08/06/1997 | CN1156451A Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 08/06/1997 | CN1156410A Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
| 08/06/1997 | CN1156404A Antibacterial oil-in-water emulsions |
| 08/05/1997 | US5654340 Method of using gulonic acid or gulonolactone for treating wrinkles |
| 08/05/1997 | US5654336 Methods of using glycolic acid for reversing or retarding the effect of aging on human facial skin |
| 08/05/1997 | US5654334 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester |
| 08/05/1997 | US5654333 Methods for prevention of cancer using phenylacetic acids and derivatives thereof |
| 08/05/1997 | US5654313 Administering a prolactin-inhibiting compound and subsequently a prolactin-stimulating compound |
| 08/05/1997 | US5654312 Cytokine and/or growth factor inhibition |
| 08/05/1997 | US5654281 Inhibiting the development of tolerance to and/or dependence on an addictive substance |
| 08/05/1997 | US5654145 Trophinin and trophinin-assisting nucleic acids and methods of detection thereof |
| 08/05/1997 | US5653992 Polylactones; drug delivery |
| 08/05/1997 | US5653962 Aerosol formulations containing P134a and particulate medicaments |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997026918A2 Ligand directed enzyme prodrug therapy |
| 07/31/1997 | WO1997026916A1 Obesity protein analog compounds and formulations thereof |
| 07/31/1997 | WO1997026886A1 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 07/31/1997 | WO1997026885A1 Benzophenothiazine and benzoporphyrin dye combination photodynamic therapy of tumors |
| 07/31/1997 | WO1997026884A1 Method for treating sexual dysfunctions |
| 07/31/1997 | WO1997026883A1 Modulation of th1/th2 cytokine expression by ribavirin® and ribavirin® analogs in activated t-lymphocytes |
| 07/31/1997 | WO1997026882A1 Nucleoside analogs in combination therapy of herpes simplex infections |
| 07/31/1997 | WO1997026880A2 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
| 07/31/1997 | WO1997026867A2 Solid instant-release forms of administration and process for producing the same |
| 07/31/1997 | WO1997026866A2 Preparations of non-steroidal analgesics |
| 07/31/1997 | WO1997026862A2 Improved concentrated injection and infusion solutions for intravenous administration |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | WO1997015269A3 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 07/31/1997 | DE19604231A1 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen A pharmaceutical combination preparation, and its use for the treatment of gynecological disorders |
| 07/31/1997 | DE19602757A1 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung Fixed instant release dosage forms and methods for their preparation |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2243964A1 Solid instant-release forms of administration and processes for their production |
| 07/31/1997 | CA2242761A1 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786264A2 Devices for treating pulmonary vasoconstriction and asthma |
| 07/30/1997 | EP0786255A1 Methods of improving allograft or xenograft tolerance by administration of an LFA-3 or CD2 binding protein |
| 07/30/1997 | EP0786253A1 Agent for suppressing tumour growth |
| 07/30/1997 | EP0786251A2 Topical preparation containing a suspension of solid lipid particles |
| 07/30/1997 | EP0786083A1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings |
| 07/30/1997 | EP0785801A1 Treatment of tissues to reduce subsequent response to injury |
| 07/30/1997 | EP0785788A1 Use of cck-b receptor antagonists for the treatment of sleep disorders |
| 07/30/1997 | EP0785778A1 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| 07/30/1997 | EP0785771A1 Treatment of pulmonary conditions associated with insufficient secretion of surfactant |
| 07/29/1997 | US5652274 Therapeutic-wound healing compositions and methods for preparing and using same |
| 07/29/1997 | US5652273 Reduction of hair growth |
| 07/29/1997 | US5652267 Method of using saccharic acid or saccharolactone for treating wrinkles |
| 07/29/1997 | US5652261 Administering vitamin e mixture; sunscreen, antiinflammatory, antiaging, and wound healing agents |
| 07/29/1997 | US5651989 Iron/carbon particles for drug delivery, using an external magnetic field to direct drug to target area inside body |
| 07/29/1997 | US5651986 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 07/29/1997 | US5651985 Expandable pharmaceutical forms |
| 07/29/1997 | US5651957 Administering lantibiotic |
| 07/29/1997 | CA1339081C Delayed release formulations |
| 07/24/1997 | WO1997026535A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026353A1 ALANYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026352A1 STAPHYLOCOCCUS AUREUS SERYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026350A1 STAPHYLOCOCCUS AUREUS METHIONYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026348A1 ASPARAGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026341A1 CYSTEINYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026336A1 Compositions for treating anemia |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026275A1 Protein occlusion for delivery of small molecules |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026014A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | WO1997025994A1 Control of healing process |
| 07/24/1997 | WO1997025981A1 Medical use |
| 07/24/1997 | WO1997025969A1 Method of inhibiting photoaging of skin |
| 07/24/1997 | WO1997021993A3 Nuclear receptor ligands and ligand binding domains |
| 07/24/1997 | DE19602206A1 Zubereitungen nichtsteroidaler Analgetika Preparations of non-steroidal analgesics |
| 07/24/1997 | DE19602111A1 New active agent combinations useful in cosmetic and dermatological compositions |
| 07/24/1997 | CA2844461A1 Compositions for treating anemia |
| 07/24/1997 | CA2243531A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | CA2243470A1 Recombinant aav virion for expressing epo in a mammal |
| 07/24/1997 | CA2242376A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | CA2241983A1 Control of healing process |
| 07/24/1997 | CA2240199A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785270A1 Staphylococcus aureus Seryl-tRNA synthetase |
| 07/23/1997 | EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785268A1 Staphylococcus aureus methionyl-tRNA synthetase |